Sofinnova Investments is a venture capital firm specializing in the life sciences sector, focusing on the development and commercialization of innovative biopharmaceuticals. With over 100 years of combined experience in investing and operating within the life sciences industry, Sofinnova has a proven track record of supporting transformative companies from inception through to successful exits. The firm has been instrumental in funding 115 companies, leading to 53 IPOs, 30 mergers and acquisitions, and 31 FDA-approved drugs.

Their expertise spans the entire lifecycle of a biopharmaceutical company, from drug development and regulatory processes to company building and IPOs. Sofinnova's collaborative approach and deep industry knowledge make them a trusted partner for entrepreneurs aiming to bring groundbreaking medical solutions to market.